| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Chemistry and Biochemistry (M.M.M., B.M.W., J.N.M.,
S.M.B., J.W.O., T.S.E.) Department of Microbiology (G.F.B.)
Brigham Young University Provo, Utah 84602
University of
Alabama at Birmingham Vascular Biology and Hypertension Program
(C.R.W.) Birmingham, Alabama 35294
Human tissues that express the angiotensin II (Ang II) type 1 receptor (hAT1R) can synthesize four distinct alternatively spliced hAT1R mRNA transcripts. In this study, we show that the relative abundance of these mRNA transcripts varies widely in human tissues, suggesting that each splice variant is functionally distinct. Here we demonstrate, for the first time, that the hAT1R-B mRNA splice variant encodes a novel long hAT1R isoform in vivo that has significantly diminished affinity for Ang II (i.e. >3-fold) when compared with the short hAT1R isoform (encoded by hAT1R-A mRNA splice variant). This reduced agonist affinity caused a significant shift to the right in the dose-response curve for Ang II-induced inositol trisphosphate production and Ca2+ mobilization of the long hAT1R when compared with that of the short hAT1R. The functional differences between these isoforms allows Ang II responsiveness to be fine-tuned by regulating the relative abundance of the long and short hAT1R isoform expressed in a given human tissue.
This article has been cited by other articles:
![]() |
M. M. Martin, J. A. Buckenberger, J. Jiang, G. E. Malana, G. J. Nuovo, M. Chotani, D. S. Feldman, T. D. Schmittgen, and T. S. Elton The Human Angiotensin II Type 1 Receptor +1166 A/C Polymorphism Attenuates MicroRNA-155 Binding J. Biol. Chem., August 17, 2007; 282(33): 24262 - 24269. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Elton and M. M. Martin Angiotensin II Type 1 Receptor Gene Regulation: Transcriptional and Posttranscriptional Mechanisms Hypertension, May 1, 2007; 49(5): 953 - 961. [Full Text] [PDF] |
||||
![]() |
R. B. Yates and M. Stafford-Smith The genetic determinants of renal impairment following cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 314 - 326. [Abstract] [PDF] |
||||
![]() |
R. T. Cowling, X. Zhang, V. C. Reese, M. Iwata, D. Gurantz, W. H. Dillmann, and B. H. Greenberg Effects of cytokine treatment on angiotensin II type 1A receptor transcription and splicing in rat cardiac fibroblasts Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1176 - H1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wu, H. Kamma, M. Fujiwara, Y. Yano, H. Satoh, H. Hara, T. Yashiro, E. Ueno, and Y. Aiyoshi Altered Expression Patterns of Heterogeneous Nuclear Ribonucleoproteins A2 and B1 in the Adrenal Cortex J. Histochem. Cytochem., April 1, 2005; 53(4): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kanaide, T. Ichiki, J. Nishimura, and K. Hirano Cellular Mechanism of Vasoconstriction Induced by Angiotensin II: It Remains To Be Determined Circ. Res., November 28, 2003; 93(11): 1015 - 1017. [Full Text] [PDF] |
||||
![]() |
Y. Zhou, Y. Chen, W. P. Dirksen, M. Morris, and M. Periasamy AT1b Receptor Predominantly Mediates Contractions in Major Mouse Blood Vessels Circ. Res., November 28, 2003; 93(11): 1089 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Johren, C. Golsch, A. Dendorfer, F. Qadri, W. Hauser, and P. Dominiak Differential Expression of AT1 Receptors in the Pituitary and Adrenal Gland of SHR and WKY Hypertension, April 1, 2003; 41(4): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. McLaughlin, C. D. Thulin, S. M. Bray, M. M. Martin, T. S. Elton, and B. M. Willardson Regulation of Angiotensin II-induced G Protein Signaling by Phosducin-like Protein J. Biol. Chem., September 13, 2002; 277(38): 34885 - 34895. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |